Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Effect of camel milk on glycemic control and insulin requirement in patients with type 1 diabetes: 2-years randomized controlled trial



Hypoglycemic effect of camel milk supplementation in experimental rat model and significant reduction in doses of insulin in type 1 diabetic patients have been observed in our previous studies. This long-term study was undertaken to assess the efficacy, safety and acceptability of camel milk as an adjunct to insulin therapy in type 1 diabetics.


In this 2-year randomized clinical, parallel design study, 24 type 1 diabetics were enrolled and divided into two groups. Group I (n=12) received usual care, that is, diet, exercise and insulin and Group II (n=12) received 500 ml camel milk in addition to the usual care. Insulin requirement was titrated weekly by blood glucose estimation. Results were analyzed by using the regression technique.


In camel milk group, there was decrease in mean blood glucose (118.58±19–93.16±17.06 mg/dl), hemoglobin A1c levels (7.81±1.39–5.44±0.81%) and insulin doses (32.50±9.99–17.50±12.09 U/day, P<0.05). Out of 12 subjects receiving camel milk, insulin requirement in 3 subjects reduced to zero. There was nonsignificant change in plasma insulin and anti-insulin antibodies in both the groups.


It may be stated that camel milk is safe and efficacious in improving long-term glycemic control, with a significant reduction in the doses of insulin in type 1 diabetic patients.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1


  • Abu-Lehia IH, Al-Mohizea IS, El-Behary M (1989). Studies on the production of ice cream from camel milk products. Aust J Dairy Technol 44, 31–34.

    Google Scholar 

  • Agamy El, Ruppanner R, Ismail A (1992). Antibacterial and antiviral activity of camel milk protective proteins. J Dairy Res 59, 169–175.

    Article  Google Scholar 

  • Agrawal RP, Beniwal R, Sharma S, Kochar DK, Tuteja FC, Ghorui SK et al. (2005). Camel milk as an adjunct to insulin therapy improves long-term glycemic control and reduction in doses of insulin in patients with type-1 diabetes – a 1 year randomized controlled trial. Diabetes Res Clin Prac 68, 176–177.

    Article  CAS  Google Scholar 

  • Agrawal RP, Singh G, Nayak KC, Kochar DK, Sharma RC, Beniwal R et al. (2004). Prevalence of diabetes in camel milk consuming ‘RAICA’ rural community of North West Rajasthan. Int J Diab Dev Countries 24, 109–114.

    Google Scholar 

  • Agrawal RP, Swami SC, Beniwal R, Kochar DK, Sahani MS, Tuteja FC et al. (2003). Effect of camel milk on glycemic control, lipid profile and diabetes quality of life in type-1 diabetes: a randomised prospective controlled cross over study. Indian J Anim Sci 73, 1105–1110.

    Google Scholar 

  • Agrawal RP, Swami SC, Beniwal R, Kochar DK, Kothari RP (2002). Effect of camel milk on glycemic control, risk factors and diabetes quality of life in type-1 diabetes: a randomised prospective controlled study. Int J Diab Dev Countries 22, 70–74.

    Google Scholar 

  • Beg OU, Von Bahr-Lind Strom H, Zaidi ZH, Jornvall H (1986). A camel milk protein rich in half cystine. Primary structure assessment of variations, internal repeat patterns and relationship with neurophysin and other active polypeptides. Eur J Biochem 15, 195–201.

    Article  Google Scholar 

  • Cefalu WT (2004). Concept, strategies and feasibility of non-invasive insulin delivery. Diabetes Care 27, 239–246.

    Article  Google Scholar 

  • Clark PM (1999). Assays for insuin, proinsulin(s) and C-peptide. Ann Clin Biochem 36 (Suppl 5), 541–564.

    Article  CAS  Google Scholar 

  • Clement S, Still G, Kosutic G, McAllister RG (2002). Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2. Diabetes Technol Therap 4, 459–466.

    Article  Google Scholar 

  • Cohen MP, Witt J, Wu VY (1993). Purified haemoglobin preparations in the evaluation of HbA1c determination by ion exchange chromatography. Ann Clin Biochem 30, 265–271.

    Article  CAS  Google Scholar 

  • Desbuquois B, Aurbach GD (1971). Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassay. J Clin Endocrinol Metab 33, 732–738.

    Article  CAS  Google Scholar 

  • Gordberg M, Gomez-Orellana I (2003). Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov 4, 289–295.

    Article  Google Scholar 

  • Jeandidier N, Boivin S, Sapin R, Rosart-Ortega F, Uring-Lambert B, Réville P et al. (1995). Immunogenicity of intraperitoneal insulin infusion using programmable implantable devices. Diabetologia 38, 577–584.

    Article  CAS  Google Scholar 

  • Kaplan LA (1984). Glucose. Clin Chem. The CV Mosby Co.: St Louis, Toronto, Princeton, pp 1032–1036.

    Google Scholar 

  • Lewis GF, Zinman B, Groenewound Y, Vranic M, Giacca A (1996). Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes 45, 454–462.

    Article  CAS  Google Scholar 

  • Lutz B (2002). Insulin and anti diabetic activity of camel milk. J Camel Res Pract 9, 43–45.

    Google Scholar 

  • Owens DR (2002). New horizons-alternative routes for insulin therapy. Nat Rev Drug Discov 1, 529–540.

    Article  CAS  Google Scholar 

  • Singh R (2001). Annual Report of National Research Centre on Camel. National Research Centre on Camel: Rajasthan, India.

    Google Scholar 

  • Trinder P (1969). Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 22 (Suppl 2), 158–161.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to R P Agrawal.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Agrawal, R., Jain, S., Shah, S. et al. Effect of camel milk on glycemic control and insulin requirement in patients with type 1 diabetes: 2-years randomized controlled trial. Eur J Clin Nutr 65, 1048–1052 (2011).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • camel milk
  • diabetes
  • adjunctive therapy
  • glycemic control
  • insulin therapy

This article is cited by


Quick links